Pharmacy Security Risk Assessment Guide for Multi-Dose Blister Packs

Multi-dose blister packs can simplify medication administration, but each step—from storage and preparation to labeling and handoff—creates security and safety risks. Use this guide to assess how your pharmacy protects medications, preserves packaging integrity, and documents accountability.

Apply your pharmacy’s approved procedures alongside applicable federal and state requirements. Where requirements differ, follow the rules that apply to your practice and consult your compliance lead or pharmacist-in-charge.

Assess Physical Security and Authorized Access

Review where medications are stored, who can enter the preparation area, and how access is granted, monitored, and removed when staff roles change. Keep preparation areas supervised and limit access to personnel whose duties require it.

For controlled substances, use secure storage and procedures that protect against theft or loss. Keep only the quantities needed for current preparation at the work area, return stock promptly to its secured location, and reconcile amounts before and after each preparation session. DEA guidance describes secure storage in a safe or securely locked, substantially constructed cabinet for controlled substances in Schedules II–V.

Document who handled each medication, when it was accessed, what quantity was used, and how any discrepancy was resolved. Clear chain-of-custody documentation and controlled substance inventory reconciliation make unexplained differences easier to detect and investigate.

Check that preparation records, access permissions, and incident-reporting steps are current. Train staff to report missing stock, damaged packages, unexpected access, or record discrepancies promptly rather than trying to correct them informally.

Verify Blister Pack Tamper Evidence

Before filling or dispensing a pack, inspect the seals, backing, pockets, labels, and outer packaging. Look for punctures, lifted or wrinkled seals, tears, glue residue, mismatched backing, damaged compartments, or signs that a pocket was opened and resealed.

Compare the package with the manufacturer’s or pharmacy’s expected design. Do not assume every multi-dose blister pack is tamper-evident: the package must be designed so that entry leaves visible evidence. FDA describes blister or strip packs as having individual compartments whose backing cannot be separated or replaced without visible evidence of entry in the context of tamper-resistant packaging requirements for certain products.

If you find damage or cannot confidently assess tamper-evident packaging integrity, set the pack aside in a designated quarantine area. Record what you observed, preserve the package, and follow your investigation and escalation procedures before deciding whether it can be used.

Manage Controlled-Substance Returns and Repackaging

Establish written repackaging accountability procedures for controlled substances. Define who may authorize, prepare, check, and document each pack; how quantities are recorded; and how unused doses, waste, and discrepancies are handled.

Record the medication, strength, lot or source information when available, quantity issued to the preparation process, quantity placed into packs, remaining quantity, date and time, and staff involved. Require an independent check where your policy or applicable rules call for one. Reconcile records against physical stock and investigate unexplained differences promptly.

Treat medication returned in a patient’s blister pack as a return requiring assessment, not as usable stock by default. Keep it separate from inventory intended for dispensing, document receipt and disposition, and follow applicable law and pharmacy policy for return, destruction, or other handling. Do not refill or reuse a returned pack unless an authorized procedure clearly permits it.

FDA guidance recognizes that pharmacy repackaging is subject to specific conditions and legal requirements. Confirm that your procedures, labeling, and records align with the requirements that apply to your pharmacy and the products involved.

Prevent Medication Identification and Packaging Errors

Build checks into every transition: selection, preparation, final verification, and handoff. Confirm the patient, medication, strength, dosage form, and schedule against the current prescription or medication profile. Use barcode scanning or other independent verification methods when available and appropriate.

Keep one patient’s medications and materials at the workstation at a time whenever practical. Clear the work surface between patients, separate look-alike or sound-alike products, and verify that each dose is placed in the correct time-and-day compartment before sealing the pack.

Ensure labels are legible and match the contents and intended schedule. Check that the label identifies the medication and directions clearly, and that any required warnings or storage instructions are retained. Unit-dose medication identification should remain available to staff and the patient, not obscured by seals or overlapping labels.

Document the final check and any corrections. If a mismatch is found after sealing, hold the pack, follow the pharmacy’s correction procedure, and document the resolution rather than making an unrecorded change.

Protect Repackaged Doses From Environmental Exposure

Follow the medication’s labeled storage requirements and your pharmacy’s approved repackaging procedures. Assess whether the blister materials protect the medication from moisture, light, heat, and other relevant conditions; do not assume that the original container’s protection carries over after repackaging.

FDA notes that packaging changes can affect a drug’s stability and that products vulnerable to light or moisture require suitable storage or packaging protection. Use product-specific information to determine appropriate environmental stability conditions, storage practices, and any applicable beyond-use or expiration dating.

Keep prepared packs in the required temperature and humidity conditions, away from direct sunlight and heat sources. Monitor storage areas as required by policy, document excursions, and quarantine affected packs until a qualified person determines the appropriate disposition.

Do not assign a longer dating period based only on the appearance of the pack or on the original manufacturer’s expiration date. Follow your approved procedure and consult the pharmacist-in-charge when the packaging configuration or storage history is uncertain.

Evaluate Child-Access Risks

Assess whether each blister pack and its outer container provide appropriate child protection for the medication and dispensing situation. A blister format alone does not establish that a package meets child-resistant packaging requirements; requirements depend on the product and the package design.

For regulated prescription drugs, non-child-resistant packaging may be dispensed upon a specific request from the patient or prescribing practitioner, subject to applicable requirements. Confirm the request and document it according to your pharmacy’s procedure, and consider whether the patient’s home includes children or other people who could access the medication.

Explain safe storage to patients and caregivers: keep medication secured, out of sight and reach of children, and in its intended packaging. If the blister pack itself is not child-resistant, consider whether an appropriate child-resistant overpackage is available and suitable for the patient’s use.

Across every control, the goal is to keep medications secure, identifiable, intact, and properly stored from preparation through handoff. Review access controls, package inspections, documentation, environmental protections, and child-access safeguards together so weaknesses in one step do not undermine the others.

FAQs.

Where should controlled substances be stored during blister pack preparation?

Keep controlled substances in secure storage when they are not actively needed for preparation. Limit access to authorized staff, bring only the necessary amount to the work area, supervise the preparation process, and return remaining stock promptly. Document quantities and reconcile them under your pharmacy’s procedures and applicable requirements.

How can pharmacy staff identify tampering with a multi-dose blister pack?

Inspect the seals, backing, pockets, and outer packaging for punctures, lifted edges, tears, residue, mismatched materials, or evidence that a compartment was opened and resealed. Compare the pack with its expected design. If you cannot confirm its integrity, quarantine it, document the concern, and follow your investigation procedure.

What should pharmacies do with medication returned in a blister pack?

Keep the returned pack separate from usable inventory, record its receipt and condition, and follow applicable law and pharmacy policy for its disposition. Do not refill or reuse it unless an authorized procedure permits that specific action.

How should repackaged doses be protected from moisture, light, and heat?

Follow product-specific storage instructions and approved repackaging procedures. Use packaging and storage conditions appropriate to the medication’s environmental sensitivities, monitor for excursions as required, and hold potentially affected packs for review. Repackaging may change the protection provided by the original container, so do not assume its storage or dating instructions automatically transfer to a new package.